We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Immunology – News and Features

News

Stem Cells that “Fool” Immune System May Provide Vaccination for Cancer

Health Center researchers have revealed the potential for human stem cells to provide a vaccination against colon cancer.
News

Hundreds of Genes Distinguish Patients Likely to Survive Advanced Melanoma

Study lays groundwork for personalized medicine in patients with advanced skin cancer
News

Serametrix Partners with the Ludwig Institute for Cancer Research to Develop and Commercialize Serum-Based Diagnostics

Agreement combines LICR’s historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix.
News

Stem Cells Which "Fool Immune System" May Provide Vaccination for Cancer

Scientists from China have revealed the potential for human stem cells to provide a vaccination against colon cancer.
News

World’s First Engineered T Cell Receptor Trial Opens With new Cellular Therapy for HIV

Adaptimmune announces first ever clinical trial with engineered T cells designed to clear HIV infection.
News

MorphoSys Announces Clinical Milestone in Cancer Program with Bayer Schering Pharma

Companies announce filling of the documentation to initiate a Phase 1 clinical trial with eighth HuCAL antibody.
News

Bristol-Myers Squibb to Acquire Medarex

Bristol-Myers Squibb acquires proven antibody discovery technology gains full rights to promising Phase III compound, Ipilimumab.
News

Functional Dendritic Cells can be Derived from hES Using Scalable Production

Geron Corporation announce the publication of data demonstrating that dendritic cells (DCs) scalably manufactured from human embryonic stem cells (hESCs) exhibit the normal functions of naturally occurring human DCs found in the bloodstream.
News

Biovest and idis Partner to Facilitate Patient Access to Lymphoma Vaccine

Personalized anti-cancer vaccine, BiovaxID®, Targeting B-cell Lymphomas available in Europe on a named-patient basis.
News

Cancer Immunotherapy Can Use Small Numbers of Stem-Like Immune Cells to Destroy Large Tumors in Mice

New approach to stimulating immune cells enhances their anticancer activity, resulting in a powerful anti-tumor response in mice.
Advertisement